— Long-range operating plan
Preserve the vision. Sequence the risk.
Planckchron keeps all six product programs while concentrating near-term execution on HERA Nexus. Time horizons are forward-looking planning ranges. Each transition depends on evidence, customer signal, governance readiness, team capacity, and available capital.
HERA Nexus earns the right to become a business.
Define one accountable customer workflow, deliver a bounded human-supervised prototype, complete controlled external evaluation, and establish a credible path to paid-pilot activity. Capital remains concentrated here until measurable customer and technical evidence exists.
One adjacent program proves the architecture can compound.
EchoNet or Helios Autonomy advances through a documented validation plan while BioForge + GenovaX remains research-stage. Expansion depends on retained use, qualified technical review, governance readiness, and financing that does not weaken the commercial wedge.
Aetherion and PX-Phantom advance only when evidence and capital justify them.
Post-silicon compute and aerospace research remain ambitious long-range programs. No operational quantum processor, clinical product, aircraft, propulsion system, or orbital infrastructure is promised on a fixed public date. Each program advances through independently reviewable technical and legal gates.
Decision cadence
Reviewed at every material evidence and capital gate.
Each program should maintain an accountable owner, current maturity label, testable question, method, limitations, required resources, stop criteria, and written decision record. Independent review is added when qualified reviewers are formally engaged; no standing council review cadence is represented without documentation.
Important disclosures
This page contains forward-looking planning ranges, not promises or guarantees. Product performance, validation, regulatory outcomes, financing, partnerships, customer adoption, and timelines may differ materially. This page is not an offer to sell or a solicitation to buy securities.